The phrase "at the complement" is not commonly used in written English and may be unclear without context.
It could potentially be used in specific contexts related to grammar or mathematics, but it is not a standard expression.
Example: "The function evaluates the value at the complement of the given set."
Alternatives: "in the complement" or "at the complementary position".
GWAS meta-analysis confirmed previously reported association of variants at the complement factor H CFHH) (peak P = 1.5×10 -31)) and age-related maculopathy susceptibility 2 (ARMS2) (P = 4.3×10 -24)) loci, and suggested Apolipoprotein E (ApoE) polymorphisms (rs2075650; P = 1.1×10 -6)) associated with early AMD.
Furthermore, genome-wide association studies have identified AD-associated variants at the complement receptor 1 gene [ 12, 13], which correlate with a greater Aβ plaque burden and age-related cognitive decline [ 14].
Increased C4d intensity at the complement activation site may reflect thus the ineffectiveness of the immune destruction system against cancer cells, which leads to chronic activation of the complement system.
In principle, to achieve the best typing quality, large-scale association studies should ideally use pulsed-field gel analysis, but in practice few studies have the DNA resources, equipment and personnel to undertake the kind of exemplary work done at the complement C4 locus [ 50, 51].
Heat-inactivated (HI) NHS (30 min at 56 °C) was used as the complement-deficient control.
So identify that and then the third thing I would say, in terms of trying to figure out what your strengths are, is to look at the complements the people give you that you just dismiss.
Type II antibodies are less effective at triggering the complement cascade but strongly evoke direct programmed cell death.
At the same time, the complement of this strand is built into a bigger DNA structure called a scaffold.
However, recent data suggest that at least some of the complement components have the ability to contribute to neuroprotective pathways.
FLIPr at 1 μM reduced the complement classical pathway activation to ~56% and to ~26% when used at 5 μM (Fig. 3 g).
Fortunately, the active intermediates at each stage in the complement sequence become rapidly inactivated or destroyed by inhibitors if they fail to initiate the next step.
